Clinical trial
A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With…
NCT00363116 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00363116 |
|---|---|
| Title | A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients |
| Official title | An Open-Label, Comparative Trial of Two Daclizumab Dosing Strategies Versus No Induction Treatment in Combination With Tacrolimus, Mycophenolate Mofetil, and Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Roche Pharma AG Industry University of Tennessee |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients |
| Intervention type | Drug |
| Interventions | Daclizumab |
| Enrollment | 298 |
| Start date | Apr 1, 1999 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Aug 15, 2006 |
| Last update posted | Oct 25, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: